| 引用本文：杨赐然, 王瑞, 罗银, 安舒涵, 吴雨欣, 毛宗福, 崔丹.国谈药“双通道”管理政策设计的省际比较研究[J].中国卫生政策研究,2023,16(4):25-31 |
|
| 国谈药“双通道”管理政策设计的省际比较研究 |
| 投稿时间：2023-01-03 修订日期：2023-04-06 PDF全文浏览 HTML全文浏览 |
| 杨赐然1,2, 王瑞1,2, 罗银1,2, 安舒涵1,2, 吴雨欣1,2, 毛宗福1,2, 崔丹1,2 |
1. 武汉大学公共卫生学院 湖北武汉 430071;
2. 武汉大学全球健康研究中心 湖北武汉 430072 |
| 摘要:目的：本研究旨在对比分析各省份“双通道”管理政策在响应时间、与原有保障政策的衔接模式和具体多维政策内容等方面的异同，以期发现不足，提炼经验，为优化“双通道”管理政策提供参考。方法：利用时间趋势分析，对各省份响应28号文的时间进行了刻画和描述，同时基于内容分析法提炼文本信息，以此对各省份“双通道”管理政策展开多尺度比较。结果：各省份的“双通道”管理政策在萌发和响应时间、与原有保障政策的衔接模式、医药机构遴选要求、限制性因素削弱和国谈药待遇保障水平等方面存在明显差距。结论：未来应从优化政策衔接、明确遴选条件、削弱不利因素和缩小待遇差距等方面进一步完善“双通道”管理政策的设计，促进国谈药落地，提升保障水平。 |
| 关键词:“双通道”管理 国谈药 政策设计 比较研究 |
| 基金项目:比尔及梅琳达·盖茨基金会项目(OOP1148464、OPP1199760) |
|
| Inter-provincial comparative study on the design of “Dual-channel” management policies for national health insurance negotiated drugs |
| YANG Ci-ran1,2, WANG Rui1,2, LUO Yin1,2, AN Shu-han1,2, WU Yu-xin1,2, MAO Zong-fu1,2, CUI Dan1,2 |
1. School of Public Health, Wuhan University, Wuhan Hubei 430071, China;
2. Global Health Institute, Wuhan University, Wuhan Hubei 430072, China |
| Abstract:Objective: This study aims to compare and analyze the similarities and differences between the “dual-channel” management policies of various provinces in terms of response time, connection mode with the original safeguard policy, and specific multidimensional policy content，in order to find the shortcomings, refine the experience, and provide reference for optimizing the “dual-channel” management policies. Methods: Using the time trend analysis, the time of each province's response to Document No. 28 was depicted and described, and the text information was extracted based on the content analysis method to carry out a multi-scale comparison of the “dual-channel” management policies of various provinces. Results: There are obvious gaps in the “dual-channel” management policies of various provinces in terms of germination and response time, the connection mode with the original safeguard policies, the selection requirements of medical institutions, the weakening of restrictive factors, and the guarantee level of national drug treatment. Conclusions: the design of the “dual-channel” management policy should be further improved from the aspects of optimizing policy convergence, clarifying selection conditions, weakening unfavorable factors and narrowing the treatment gap, so as to promote the landing of national drugs and improve the level of protection. |
| Key words:“Dual-channel” management National medical insurance negotiated drugs Policy design Comparative study |
| 摘要点击次数: 951 全文下载次数: 1160 |
|
|
|
|
|
